Scheduled Speakers

Donald Stuss

Matthew Norton

Shiva Amiri

Igor Jurisica

Brendan Johns

Khaled El Emam

Peter Snelling

Donald Stuss, President and Scientific Director

Donald Stuss Donald T. Stuss, Ph.D., C. Psych., ABPP-CN, Order of Ontario, FRSC, FCAHS, is the President and Scientific Director of the Ontario Brain Institute (2011- present); University of Toronto Professor of Medicine (Neurology and Rehabilitation Science) and Psychology; a Senior Scientist at the Rotman Research Institute of Baycrest Centre (currently adjunct); founding Director of the Rotman Research Institute, from 1989 to 2008, Reva James Leeds Chair in Neuroscience and Research Leadership 2001-2009, and Vice-President Research, at Baycrest, 1991-2004, 2006-2009; Vice-President Academic Education at Baycrest 2006-2008; interim Director and CEO of the Heart and Stroke Foundation Centre for Stroke Recovery 2008-2009. His personal research focuses on understanding and treating the cognitive functions and personality changes associated with the frontal lobes as they occur after stroke, normal elderly, and in those with traumatic brain injury or dementia. He has one co-authored book, and four co-edited books; over 200 publications and 49 chapters; and presented over 250 invited scientific lectures and workshops.

Title:

Generating Big Data in Neuroscience: Changing the System

Abstract:

The major theme of this presentation is that gathering big data must be driven by a scientific vision, and that this requires system innovation. The Ontario Brain Institute was founded to address salient neurological and mental health disorders. The structure of OBI was founded on several principles and assumptions: e.g., patient focused to drive improved clinical care and service delivery; inter-disciplinary to provide as full a picture of each individual as possible; multi-institutional to include largest possible number of individuals for research, patient stratification, and clinical implementation; early involvement of industry in a non-competitive manner to maximize development of health products in Ontario. Although disease focused, the scientific vision underlying OBI is that brain disorders are heterogeneous from genes to pathology to social and individual expression. That is, the system must be set up to address relationships not only within a disease, but also across diseases. Big insights will be gained not from big data alone, but from big data gathered from strategic systemic change.